key: cord-1039000-4y0vex9m
authors: Koskinen, M.; Carpen, O.; Honkanen, V.; Seppänen, M.R.J.; Miettinen, P.J.; Tuominen, J.A.; Raivio, T.
title: Androgen deprivation and SARS-CoV-2 in men with prostate cancer
date: 2020-06-29
journal: Ann Oncol
DOI: 10.1016/j.annonc.2020.06.015
sha: b994878e0479e3742305b8959b8e941c82965767
doc_id: 1039000
cord_uid: 4y0vex9m

nan

We read with great interest the very recent article by Montopoli et al., which reports men with prostate cancer tested for SARS-CoV-2 in Veneto, Italy, by April 1, 2020 (1). The authors suggest that androgen deprivation therapy (ADT) could partially protect from SARS-CoV-2 infection (1).

The biological premise for this observation is the androgen receptor-mediated regulation of TMPRSS2 (2), a type II transmembrane serine protease that is important for SARS-CoV-2 entry to host cells (3) . Indeed, androgens regulate TMPRSS2 expression also in a lung carcinoma cell line (4) . A patient was classified to be on ADT if he had a history of orchiectomy, or a valid prescription for a GnRH analogue, GnRH antagonist, and/or antiandrogens (flutamide, bicalutamide, enzalutamide) or the CYP17 inhibitor abiraterone before his SARS-CoV-2 test (n=134) (38%, 95% CI: 33%-43%). The mean age of these 134 men was 78.4 yrs ± 8.1 SD (range 58-96 yrs). The frequency of being on ADT was in agreement with that observed in a survey of a large cohort of UK men with prostate cancer (5) . Conversely, a patient was classified not to be on ADT if no records of the above conditions were found or ADT had been ceased before a SARS-CoV-2 test 0.10 § Fisher exact test # ICD-10 codes I10 and I15 ¤ ICD-10 codes I20, I21, I24 and I25 ¥ ICD-10 code J44 £ ICD-10 code E11 Ω ICD-10 codes I48 and I49

Androgen-deprivation therapies for prostate cancer and risk of infection by SARSCoV-2: a population-based study (n=4532)

Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer

Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Androgen receptor and androgen-dependent gene expression in lung

Key factors associated with social distress after prostate cancer: Results from the United Kingdom Life after Prostate Cancer diagnosis study

Risk Factors of Critical & Mortal COVID-19 Cases: A Systematic Literature Review and Meta-Analysis

COVID-19 Cases (Coronavirus Disease) in Veneto as well as related information and services (Wikipedia, Google, images)

Population estimates (1/1/2019) of all provinces in the region of Veneto